Influence of ursodeoxycholic acid on insulin resistance in patients with metabolic syndrome
Full Text:PDF (Українська)
Maev IV, Kucheriavyi IuA, Morozov SV, et al. Efficiency and tolerability of ursodeoxycholic acid as monotherapy and in combination with lactulose in patients with non-alcoholic steatohepatitis. Klinicheskie perspektivy gastroenterologii, gepatologii. 2012;(2):3-12.
Pathil A1, Mueller J, Warth A, Chamulitrat W, Stremmel W. Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease. Hepatology. 2012 May;55(5):1369-78. doi: 10.1002/hep.25531.
Troisi G, Crisciotti F, Gianturco V, et al. The treatment with ursodeoxycholic acid in elderly patients affected by NAFLD and metabolic syndrome: a case-control study. Clin Ter. 2013 May-Jun;164(3):203-7. doi: 10.7417/CT.2013.1550.
Tsuchida T, Shiraishi M, Ohta T, Sakai K, Ishii S. Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice. Metabolism. 2012 Jul;61(7):944-53. doi: 10.1016/j.metabol.2011.10.023.
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 4.0 International License.
© "Publishing House "Zaslavsky", 1997-2018